According to Amicus Therapeutics 's latest financial reports the company's total assets are A$1.25 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | A$1.26 B | 10.54% |
2023-12-31 | A$1.14 B | 7.29% |
2022-12-31 | A$1.06 B | -14.76% |
2021-12-31 | A$1.24 B | 8.29% |
2020-12-31 | A$1.15 B | -5.06% |
2019-12-31 | A$1.21 B | 8.29% |
2018-12-31 | A$1.12 B | 39.62% |
2017-12-31 | A$0.80 B | -44.16% |
2016-12-31 | A$1.43 B | 15.36% |
2015-12-31 | A$1.24 B | 386.02% |
2014-12-31 | A$0.25 B | 79.4% |
2013-12-31 | A$0.14 B | 35% |
2012-12-31 | A$0.10 B | 55.63% |
2011-12-31 | A$68.06 M | -38.57% |
2010-12-31 | A$0.11 B | 16.59% |
2009-12-31 | A$95.03 M | -47.93% |
2008-12-31 | A$0.18 B | -4.5% |
2007-12-31 | A$0.19 B | 152.6% |
2006-12-31 | A$75.66 M | 93.1% |
2005-12-31 | A$39.18 M | |
2003-12-31 | A$0.67 M |